Examining the influence of tumor-infiltrating macrophages on breast cancer outcomes and identifying relevant genes for diagnostic purposes
- PMID: 39331271
- PMCID: PMC11436547
- DOI: 10.1007/s12672-024-01397-z
Examining the influence of tumor-infiltrating macrophages on breast cancer outcomes and identifying relevant genes for diagnostic purposes
Abstract
Objective: The purpose of this research was to investigate how different types of immune cells impact the outlook of individuals with breast cancer, as well as identify the essential genes associated with immune cell subtype enrichment.
Methods: The Cancer Genome Atlas (TCGA) database and Gene Expression Omnibus (GEO) database were used to obtain global transcriptome sequencing data sets of breast tissue. The study utilized the CIBERSORT algorithm to determine the presence of 22 different types of immune cells in both breast cancer tissue and normal breast tissue.Immune cell infiltration content was utilized to conduct univariate COX analysis in order to identify risk factors linked to breast cancer prognosis.
Results: Univariate COX analysis indicates that Macrophages M1 and B cells naive are beneficial factors for the outlook of individuals with breast cancer (P < 0.05), while Macrophages M2 and Monocytes are detrimental factors for the prognosis of breast cancer patients (P < 0.05). The high infiltration group of macrophage M2 had a poorer prognosis compared to the low infiltration group (P < 0.001); Conversely, the high infiltration group of macrophage M1 had a better prognosis than the low infiltration group (P = 0.002).
Conclusion: The study provided an overview of immune cell infiltration in breast cancer tissues, identifying macrophage M1 and macrophage M2 as potential factors in breast cancer development and progression. Additionally, genes associated with macrophage phenotype were analyzed, offering insights into macrophage polarization mechanisms.
Keywords: Breast cancer; Immune cells; Prognosis.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.Front Oncol. 2021 Dec 3;11:769727. doi: 10.3389/fonc.2021.769727. eCollection 2021. Front Oncol. 2021. PMID: 34926275 Free PMC article.
-
Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization.Am J Physiol Cell Physiol. 2024 Jan 1;326(1):C252-C268. doi: 10.1152/ajpcell.00234.2023. Epub 2023 Nov 20. Am J Physiol Cell Physiol. 2024. PMID: 37982173
-
M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.Front Immunol. 2020 Nov 16;11:560074. doi: 10.3389/fimmu.2020.560074. eCollection 2020. Front Immunol. 2020. PMID: 33304345 Free PMC article.
-
Screening of coexpression genes of immune cells in breast cancer tissues.Medicine (Baltimore). 2024 Jan 5;103(1):e36211. doi: 10.1097/MD.0000000000036211. Medicine (Baltimore). 2024. PMID: 38181289 Free PMC article.
-
Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.Front Immunol. 2021 Oct 1;12:736030. doi: 10.3389/fimmu.2021.736030. eCollection 2021. Front Immunol. 2021. PMID: 34659224 Free PMC article.
References
-
- Loibl S, Poortmans P, Morrow M, et al. Breast cancer. Lancet. 2021;397(10286):1750–69. - PubMed
-
- Harbeck N, Penault-Llorca F, Cortes J, et al. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66. - PubMed
-
- Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321(3):288–300. - PubMed
-
- Woolston C. Breast cancer. Nature. 2015;527(7578):S101. - PubMed
-
- Martin RF. Breast Cancer. Surg Clin North Am. 2023;103(1):xiii-xiv. - PubMed
LinkOut - more resources
Full Text Sources